Wikisage, the free encyclopedia of the second generation, is digital heritage
Doripenem: Difference between revisions
Jump to navigation
Jump to search
m (File:Doripenem_vert1.jpg) |
No edit summary |
||
| Line 15: | Line 15: | ||
<ref>[https://www.whocc.no/atc_ddd_index/?code=J01DH04 J01DH04]</ref></center> | <ref>[https://www.whocc.no/atc_ddd_index/?code=J01DH04 J01DH04]</ref></center> | ||
|} | |} | ||
<ref>[https://karmel.miraheze.org/m/6Sy | <ref>[https://karmel.miraheze.org/m/6Sy karmel(miraheze) es:Doripenem]</ref> | ||
{{refs}} | {{refs}} | ||
Latest revision as of 21:28, 2 September 2021
Doripenem is a beta-lactam antibiotic agent belonging to the carbapenem group
|
Seizures have been reported during treatment with doripenem (see section 6.2). In clinical trials, doripenem-treated patients with pre-existing central nervous system (CNS) disorders (e.g. stroke or history of seizures), patients with compromised renal function and patients given doses greater than 500 mg every 8 hours appear to be at greater risk for developing seizures [1] |
ATC
|
| References: |